Neurogastrx Bags $45M, a New CEO and a HQ Move to the Greater Boston Area Post author:Sam Post published:January 3, 2018 Post category:BioPharma The Series A financing was co-led by 5AM Ventures, OrbiMed Advisors and venBio Partners. Source: BioSpace You Might Also Like Sanofi Falls Short of Q3 Expectations, Terminates Phase II Lung Drug From Pipeline November 1, 2017 Race Heats Up As Mallinckrodt Gets Bids August 8, 2017 Former Eli Lilly Exec Expected to be Named Trump's HHS Secretary November 9, 2017
